Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | CHKA | P35790 | 1/20 | 0.47 |
| ▸ | GNAI3 | P08754 | 5/20 | 0.45 |
| ▸ | GNAO1 | P09471 | 5/20 | 0.45 |
| ▸ | GNAI1 | P63096 | 5/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.44 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.44 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.44 |
| ▸ | CHRNB3 | Q05901 | 1/20 | 0.44 |
| ▸ | CHRNA6 | Q15825 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL23778449 | 0.98 | L3MBTL1 (0.50) | L3MBTL1MEN1KMT2ATDP1CA2 | |
| SCHEMBL10514 | 0.92 | GNAI3 (0.50) | L3MBTL1MEN1KMT2ATDP1CA2 | |
| Hydrochloric Acid SCHEMBL2578850 | 0.90 | GNAI3 (0.53) | L3MBTL1MEN1KMT2ATDP1CA2 | |
| SCHEMBL19788225 | 0.86 | L3MBTL1 (0.69) | L3MBTL1MEN1KMT2ATDP1GNAI3 | |
| SCHEMBL13138626 | 0.85 | CA2 (0.50) | L3MBTL1MEN1KMT2ATDP1CA2 | |
| SCHEMBL9762642 | 0.82 | — | — | |
| SCHEMBL805464 | 0.82 | L3MBTL1 (0.72) | L3MBTL1MEN1KMT2ATDP1GNAI3 | |
| SCHEMBL10617306 | 0.81 | CHRNB2 (0.52) | L3MBTL1MEN1KMT2ATDP1CA2 | |
| SCHEMBL2998705 | 0.81 | L3MBTL1 (0.60) | L3MBTL1MEN1KMT2ATDP1GNAI3 | |
| SCHEMBL12578188 | 0.81 | CNR1 (0.43) | L3MBTL1MEN1KMT2ATDP1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024134947-A1 | MULTILAYER COATING FILM FORMATION METHOD | 日産自動車株式会社 | 2024-06-27 | — | — | WO | disclosed |
| EP-3399001-B1 | AQUEOUS COATING MATERIAL COMPOSITION AND COATING FILM FORMING METHOD | NIPPON PAINT AUTOMOTIVE COATINGS CO LTD (JP) | 2022-10-12 | — | — | EP | disclosed |
| CN-108883432-B | Method for forming multilayer coating film | 日涂汽车涂料有限公司 | 2021-08-06 | — | — | CN | disclosed |
| EP-3409378-B1 | METHOD FOR FORMING MULTILAYER COATING FILM | NIPPON PAINT AUTOMOTIVE COATINGS CO LTD (JP) | 2021-01-13 | — | — | EP | disclosed |
| US-10870765-B2 | Aqueous coating composition and method for forming a coating film | NIPPON PAINT AUTOMOTIVE COATINGS CO., LTD. (JP) | 2020-12-22 | — | — | US | disclosed |
| US-20200283639-A1 | AQUEOUS COATING COMPOSITION AND METHOD FOR FORMING A COATING FILM | NIPPON PAINT AUTOMOTIVE COATINGS CO., LTD. (JP) | 2020-09-10 | — | — | US | disclosed |
| US-10696866-B2 | Method for forming multilayer coating film | NIPPON PAINT AUTOMOTIVE COATINGS CO., LTD. (JP) | 2020-06-30 | — | — | US | disclosed |
| US-20190031915-A1 | METHOD FOR FORMING MULTILAYER COATING FILM | NIPPON PAINT AUTOMOTIVE COATINGS CO., LTD. (JP) | 2019-01-31 | — | — | US | disclosed |
| US-10174428-B2 | Etchant, replenishment solution and method for forming copper wiring | MEC COMPANY LTD. (JP) | 2019-01-08 | — | — | US | disclosed |
| EP-3409378-A1 | METHOD FOR FORMING MULTILAYER COATING FILM | Nippon Paint Automotive Coatings Co., Ltd. (JP) | 2018-12-05 | — | — | EP | disclosed |
| EP-3399001-A1 | AQUEOUS COATING MATERIAL COMPOSITION AND COATING FILM FORMING METHOD | Nippon Paint Automotive Coatings Co., Ltd. (JP) | 2018-11-07 | — | — | EP | disclosed |
| US-20170260632-A1 | ETCHANT, REPLENISHMENT SOLUTION AND METHOD FOR FORMING COPPER WIRING | MEC COMPANY LTD. (JP) | 2017-09-14 | — | — | US | disclosed |
| WO-2017133517-A1 | PHOSPHAMIDE DERIVATIVE, METHOD FOR MANUFACTURING THE SAME, AND USES THEREOF | 四川海思科制药有限公司 | 2017-08-10 | — | — | WO | disclosed |
| US-9156937-B2 | Block polyisocyanate composition and coating composition containing same | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2015-10-13 | — | — | US | disclosed |
| EP-2535364-B1 | BLOCK POLYISOCYANATE COMPOSITION AND COATING COMPOSITION CONTAINING SAME | ASAHI KASEI CHEMICALS CORP (JP) | 2015-01-21 | — | — | EP | disclosed |
| EP-2535364-A1 | BLOCK POLYISOCYANATE COMPOSITION AND COATING COMPOSITION CONTAINING SAME | Asahi Kasei Chemicals Corporation (JP) | 2012-12-19 | — | — | EP | disclosed |
| US-20120316291-A1 | BLOCK POLYISOCYANATE COMPOSITION AND COATING COMPOSITION CONTAINING SAME | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2012-12-13 | — | — | US | disclosed |
| EP-1592408-B1 | SUSTAINED RELEASE DEVICE AND METHOD FOR OCULAR DELIVERY OF ADRENERGIC AGENTS | PSIVIDA INC (US) | 2009-08-26 | — | — | EP | disclosed |
| US-6313294-B1 | Process for preparing amides | DEVELOPMENT CENTER FOR BIOTECHNOLOGY (TW) | 2001-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120316291-A1 | BLOCK POLYISOCYANATE COMPOSITION AND COATING COMPOSITION CONTAINING SAME | AKR1B1, AKR1A1, KYAT1 | L3MBTL1 2229/4885MEN1 3950/4885KMT2A 205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.